webinar register page

Webinar banner
2022 MLK Health Sciences: Interdisciplinary Panel Discussion "Racial / Ethnic Disparities in Pain Management"
The 2022 MLK Health Sciences Committee presents an Interdisciplinary Panel Discussion on "Racial / Ethnic Disparities in Pain Management." Our panelists will discuss their experiences with this issue and will share their insights regarding potential solutions.

Panelists:
Dr. Mary Janevic – MPH, PhD - Associate Research Scientist, Health Behavior & Health Education – School of Public Health, University of Michigan

Dr. Sheria Robinson-Lane, PhD, RN, MHA - Assistant Professor, Department of Systems, Populations and Leadership – School of Nursing, University of Michigan

Dr. Michael Smith, PharmD - Clinical Associate Professor, Department of Clinical Pharmacy - College of Pharmacy and Clinical Pharmacist, Pain and Palliative Care - Michigan Medicine, University of Michigan

Feb 17, 2022 12:00 PM in Eastern Time (US and Canada)

* Required information
Loading

Speakers

Dr. Mary Janevic – MPH, PhD
Associate Research Scientist, Health Behavior & Health Education – School of Public Health @School of Public Health - University of Michigan
Mary Janevic is an Associate Research Scientist in Health Behavior/Health Education at the University of Michigan School of Public Health. Her research centers around promoting healthy aging, particularly in underserved populations, using community-engaged research methods. A major focus of her work is disparities in chronic pain and developing chronic pain self-management interventions for vulnerable populations. Related areas of interest are community health workers, mobile health solutions for chronic pain management, and the role of pets in coping with chronic pain. Previously Dr. Janevic was a post-doctoral fellow at the Department of Epidemiology and Public Health at University College London, UK, where she assisted with the English Longitudinal Study on Ageing. She has also worked at Kaiser Permanente-Northern California Region, where she coordinated health education programs focusing on chronic disease management.
Dr. Sheria Robinson-Lane, PhD, RN, MHA
Assistant Professor, Department of Systems, Populations and Leadership @School of Nursing - University of Michigan
Dr. Sheria G. Robinson-Lane is a gerontologist with expertise in palliative care, long-term care, and nursing administration. Her work aims to reduce health disparities and improve health equity for diverse older adults and family caregivers managing pain and chronic diseases such as Alzheimer’s. Dr. Robinson-Lane’s research addresses the ways in which older adults adapt to changes in health, and particularly how various coping strategies affect health outcomes. Her current work is focused on improving the ability of diverse older adults to successfully age in place through culturally responsive and community engaged care practices along with effective caregiver support. Dr. Robinson-Lane completed her Ph.D. in Nursing at Wayne State University in Detroit and a postdoctoral fellowship in Advanced Rehabilitation Research Training at the University of Michigan Medical School.
Dr. Michael Smith, PharmD
Clinical Associate Professor and Clinical Pharmacist @College of Pharmacy / Michigan Medicine - U of Michigan
Michael Smith is a Clinical Associate Professor in the Department of Clinical Pharmacy at the University of Michigan College of Pharmacy and Clinical Pharmacist in Pain and Palliative Care at Michigan Medicine. He is the Residency Program Director for the PGY2 Pain Management and Palliative Care Pharmacy Residency at Michigan Medicine. Dr. Smith received his Bachelor of Science degree in Chemistry and Doctorate of Pharmacy degree from the University of Pittsburgh. He completed a pharmacy practice and internal medicine specialty residency at the University of Pittsburgh Medical Center. He is a preceptor of the Pharmacy Residency Programs at Michigan Medicine. He is also a board certified specialist in pharmacotherapy. Areas of research interest include: safe and effective use of analgesics in centralized pain, older adult cancer survivors, and appropriate use of medications in these vulnerable patients